Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8


Elevated HOXA1 expression correlates with accelerated tumor cell proliferation and poor prognosis in gastric cancer partly via cyclin D1.

Yuan C, Zhu X, Han Y, Song C, Liu C, Lu S, Zhang M, Yu F, Peng Z, Zhou C.

J Exp Clin Cancer Res. 2016 Jan 21;35:15. doi: 10.1186/s13046-016-0294-2.


Prosaposin activates the androgen receptor and potentiates resistance to endocrine treatment in breast cancer.

Ali A, Creevey L, Hao Y, McCartan D, O'Gaora P, Hill A, Young L, McIlroy M.

Breast Cancer Res. 2015 Sep 4;17:123. doi: 10.1186/s13058-015-0636-6.


Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4).

Thakker RV.

Mol Cell Endocrinol. 2014 Apr 5;386(1-2):2-15. doi: 10.1016/j.mce.2013.08.002. Epub 2013 Aug 8. Review.


Impaired transforming growth factor-β (TGF-β) transcriptional activity and cell proliferation control of a menin in-frame deletion mutant associated with multiple endocrine neoplasia type 1 (MEN1).

Canaff L, Vanbellinghen JF, Kaji H, Goltzman D, Hendy GN.

J Biol Chem. 2012 Mar 9;287(11):8584-97. doi: 10.1074/jbc.M112.341958. Epub 2012 Jan 24.


Menin represses tumorigenesis via repressing cell proliferation.

Wu T, Hua X.

Am J Cancer Res. 2011;1(6):726-39. Epub 2011 May 16.


Clinical and molecular genetics of parathyroid neoplasms.

Sharretts JM, Simonds WF.

Best Pract Res Clin Endocrinol Metab. 2010 Jun;24(3):491-502. doi: 10.1016/j.beem.2010.01.003. Review.


Deciphering von Hippel-Lindau (VHL/Vhl)-associated pancreatic manifestations by inactivating Vhl in specific pancreatic cell populations.

Shen HC, Adem A, Ylaya K, Wilson A, He M, Lorang D, Hewitt SM, Pechhold K, Harlan DM, Lubensky IA, Schmidt LS, Linehan WM, Libutti SK.

PLoS One. 2009;4(4):e4897. doi: 10.1371/journal.pone.0004897. Epub 2009 Apr 2.

Supplemental Content

Support Center